These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 73383)

  • 1. Specific blocking factors--are they important?
    Hellström KE; Hellström I; Nepom JT
    Biochim Biophys Acta; 1977 Dec; 473(2):121-48. PubMed ID: 73383
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated immunity to mouse tumors: some recent findings.
    Hellström KE; Hellström I
    Ann N Y Acad Sci; 1976; 276():176-87. PubMed ID: 68697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors interfering with immunological rejection of tumours.
    Baldwin RW; Robins RA
    Br Med Bull; 1976 May; 32(2):118-23. PubMed ID: 782631
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current achievements in clinical oncoimmunology].
    Gorodilova VV
    Sov Med; 1977 Oct; (10):110-5. PubMed ID: 337523
    [No Abstract]   [Full Text] [Related]  

  • 5. Nutrition and tumor immunity: divergent effects of antitumor antibody.
    Bull DM
    Cancer Res; 1975 Nov; 35(11 Pt. 2):3317-9. PubMed ID: 1104143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gordian knot of tumour immunology.
    Amlot P
    Guys Hosp Rep; 1974; 123(1):43-51. PubMed ID: 4549511
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune response to a mammary adenocarcinoma. IV. Blocking of cell-mediated cytolysis by immunoglobulins binding to immune lymphocytes.
    Huber SA; Lucas ZJ
    J Immunol; 1977 Aug; 119(2):726-36. PubMed ID: 328781
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumour sensitization obtained by injection of antigenic tumour cells into the caecal lumen of syngeneic mice.
    Laursen ML; Laursen K
    Eur J Cancer (1965); 1979 Apr; 15(4):537-42. PubMed ID: 436914
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO
    Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic mechanisms in the prevention and therapy of cancer.
    Fleisher TA; Kersey JH
    Am J Dis Child; 1974 Nov; 128(5):739-42. PubMed ID: 4608684
    [No Abstract]   [Full Text] [Related]  

  • 11. Stimulation of tumor cell growth in vitro: a critical evaluation of immunologic specificity.
    Lamon EW
    J Natl Cancer Inst; 1977 Sep; 59(3):769-74. PubMed ID: 70536
    [No Abstract]   [Full Text] [Related]  

  • 12. Cellular and humoral immunity to rat hepatoma-specific antigens correlated with tumour status.
    Baldwin RW; Embleton MJ; Robins RA
    Int J Cancer; 1973 Jan; 11(1):1-10. PubMed ID: 4133609
    [No Abstract]   [Full Text] [Related]  

  • 13. Specificity of antileukemia sera prepared by immunization with leukemia cells admixed with normal antigen-blocking sera.
    Smith PJ; Robinson CM; Reif AE
    Cancer Res; 1974 Jan; 34(1):169-75. PubMed ID: 4129197
    [No Abstract]   [Full Text] [Related]  

  • 14. Some aspects of the immune defense against cancer. I. In vitro studies on animal tumors.
    Hellström KE; Hellström I
    Cancer; 1971 Nov; 28(5):1266-8. PubMed ID: 5125673
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor escape from immune elimination.
    Grossman Z; Berke G
    J Theor Biol; 1980 Mar; 83(2):267-96. PubMed ID: 6967536
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunity to murine sarcoma virus induced tumours. IV. Direct cellular cytolysis of 51Cr labelled target cells in vitro and analysis of blocking factors which modulate cytotoxicity.
    Gorczynski RM; Knight RA
    Br J Cancer; 1975 Apr; 31(4):387-404. PubMed ID: 50851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulation of host resistance in cancer therapy.
    Baldwin RW
    Springer Semin Immunopathol; 1982; 5(2):113-25. PubMed ID: 6755781
    [No Abstract]   [Full Text] [Related]  

  • 19. The specificity of effector T cells activated by tumours induced by murine oncornaviruses.
    Shellam GR; Knight RA; Mitchison NA; Gorczynski RM; Maoz A
    Transplant Rev; 1976; 29():249-76. PubMed ID: 58459
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppression of cell-mediated cytotoxicity by lymphocytes from tumor-bearing animals.
    Hellström I; Hellström KE; Kall MA; Nelson K; Pollack S
    Transplant Proc; 1976 Jun; 8(2):255-64. PubMed ID: 936286
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.